Update: $ALNY held the $125 support we mentioned on 6/8. Share price looks to break out of the downward trendline. Company is developing COVID-19 vaccine and expects human trials by year end. 
Our long target is still $146-150.
$spy $qqq #fintwit #charts $spx $aapl $fb $tsla $ibb https://t.co/TXBFsCWuH5 https://t.co/VqUlE6CpIn